PtdIns(3,4,5)P3 and inositol depletion as a cellular target of mood stabilizers

Biochemical Society Transactions

Volumn 37, Issue 5, 2009, Pages 1110-1114

  Teo, Regina ^a   King, Jason ^a,c   Dalton, Emma ^a   Ryves, Jonathan ^a   Williams, Robin S B ^b   Harwood, Adrian J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Bipolar disorder; Chemotaxis; Dictyostelium; Inositol depletion; Neuronal cell biology; Phosphatidylinositol 3,4,5 trisphosphate; Phosphatidylinositol 4,5 bisphosphate

Indexed keywords

CARBAMAZEPINE; CYCLIC AMP; GLYCOGEN SYNTHASE KINASE 3; INOSITOL; INOSITOL 1,4,5 TRISPHOSPHATASE; LITHIUM SALT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; VALPROIC ACID;

BIPOLAR DISORDER; CELL FUNCTION; CELL STRUCTURE; CHEMOTAXIS; CONFERENCE PAPER; DEPLETION; DRUG TARGETING; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CHEMOTAXIS; HUMANS; INOSITOL; LITHIUM COMPOUNDS; PHOSPHATIDYLINOSITOL PHOSPHATES; SIGNAL TRANSDUCTION; VALPROIC ACID;

DICTYOSTELIUM;

EID: 70350161413     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371110     Document Type: Conference Paper

References (44)

1. Mitchell, P.B. (1999) On the 50th anniversary of John Cade's discovery of the anti-manic effect of lithium. Aust. N. Z. J. Psychiatry 33, 623-628
2. Soares-Weiser, K., Bravo Vergel, Y., Beynon, S., Dunn, G., Barbieri, M., Duffy, S., Geddes, J., Gilbody, S., Palmer, S. and Woolacott, N. (2007) A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol. Assess. 11, iii-iv, ix-206
3. Geddes, J.R., Calabrese, J.R. and Goodwin, G.M. (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br. J. Psychiatry 194, 4-9
4. Harwood, A.J. (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117-126
5. Williams, R.S., Cheng, L., Mudge, A.W. and Harwood, A.J. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417, 292-295
6. Shimshoni, J.A., Dalton, E.C., Jenkins, A., Eyal, S., Ewan, K., Williams, R.S., Pessah, N., Yagen, B., Harwood, A.J. and Bialer, M. (2007) The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. Mol. Pharmacol. 71, 884-892
7. Shaltiel, G., Dalton, E.C., Belmaker, R.H., Harwood, A.J. and Agam, G. (2007) Specificity of mood stabilizer action on neuronal growth cones. Bipolar Disord. 9, 281-289
8. Shimshoni, J.A., Dalton, E.C., Watson, P., Yagen, B., Bialer, M. and Harwood, A.J. (2009) Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphology. Neuropharmacology 56, 831-837
9. Kim, H.J. and Thayer, S.A. (2009) Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol. Pharmacol. 75, 1021-1030
10. Gordon-Weeks, P.R. (2004) Microtubules and growth cone function. J. Neurobiol. 58, 70-83
11. Goold, R.G., Owen, R. and Gordon-Weeks, P.R. (1999) Glycogen synthase kinase 3β phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J. Cell Sci. 112, 3373-3384
12. Owen, R. and Gordon-Weeks, P.R. (2003) Inhibition of glycogen synthase kinase 3β in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones. Mol. Cell. Neurosci. 23, 626-637
13. Lucas, F.R., Goold, R.G., Gordon-Weeks, P.R. and Salinas, P.C. (1998) Inhibition of GSK-3β leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J. Cell Sci. 111, 1351-1361
14. Ryves, W.J., Dalton, E.C., Harwood, A.J. and Williams, R.S. (2005) GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disord. 7, 260-265
15. Shaltiel, G., Shamir, A., Shapiro, J., Ding, D., Dalton, E., Bialer, M., Harwood, A.J., Belmaker, R.H., Greenberg, M.L. and Agam, G. (2004) Valproate decreases inositol biosynthesis. Biol. Psychiatry 56, 868-874
16. Eickholt, B.J., Towers, G.J., Ryves, W.J., Eikel, D., Adley, K., Ylinen, L.M., Chadborn, N.H., Harwood, A.J., Nau, H. and Williams, R.S. (2005) Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3β inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol. Pharmacol. 67, 1426-1433
17. Williams, R.S., Eames, M., Ryves, W.J., Viggars, J. and Harwood, A.J. (1999) Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J. 18, 2734-2745
18. Schulz, I., Gerhartz, B., Neubauer, A., Holloschi, A., Heiser, U., Hafner, M. and Demuth, H.U. (2002) Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur. J. Biochem. 269, 5813-5820
19. Sarkar, S., Floto, R.A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L.J. and Rubinsztein, D.C. (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101-1111
20. Harwood, A.J. (2001) Signal transduction and Dictyostelium development. Protist 152, 17-29
21. Maeda, Y. (1970) Influence of ionic conditions on cell differentiation and morphogenesis of the cellular slime molds. Dev. Growth Differ. 12, 217-227
22. 3 signalling in Dictyostelium and human cells. Dis. Models Mech. 2, 306-312
23. Drayer, A.L., Van der Kaay, J., Mayr, G.W. and Van Haastert, P.J. (1994) Role of phospholipase C in Dictyostelium: formation of inositol 1,4,5-trisphosphate and normal development in cells lacking phospholipase C activity. EMBO J. 13, 1601-1609
24. 2+ signalling is not required for chemotaxis in Dictyostelium. EMBO J. 19, 4846-4854
25. Kamimura, Y., Xiong, Y., Iglesias, P.A., Hoeller, O., Bolourani, P. and Devreotes, P.N. (2008) PIP3-independent activation of TorC2 and PKB at the cell's leading edge mediates chemotaxis. Curr. Biol. 18, 1034-1043
26. Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M.L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P. et al. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105, 2052-2057
27. Zhou, F.Q., Zhou, J., Dedhar, S., Wu, Y.H. and Snider, W.D. (2004) NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC. Neuron 42, 897-912
28. Chadborn, N.H., Ahmed, A.I., Holt, M.R., Prinjha, R., Dunn, G.A., Jones, G.E. and Eickholt, B.J. (2006) PTEN couples Sema3A signalling to growth cone collapse. J. Cell Sci. 119, 951-957
29. Martín-Peña, A., Acebes, A., Rodríguez, J.R., Sorribes, A., de Polavieja, G.G., Fernández-Fuñez, P. and Ferrús, A. (2006) Age-independent synaptogenesis by phosphoinositide 3 kinase. J. Neurosci. 26, 10199-10208
30. Ramsey, M.M., Adams, M.M., Ariwodola, O.J., Sonntag, W.E. and Weiner, J.L. (2005) Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. J. Neurophysiol. 94, 247-254
31. Xu, X., Muller-Taubenberger, A., Adley, K.E., Pawolleck, N., Lee, V.W., Wiedemann, C., Sihra, T.S., Maniak, M., Jin, T. and Williams, R.S. (2007) Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid. Eukaryotic Cell 6, 899-906
32. Backman, S.A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.S., Shannon, P., Bolon, B., Ivy, G.O. and Mak, T.W. (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29, 396-403
33. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R. et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947
34. Yates, J.R. (2006) Tuberous sclerosis. Eur. J. Hum. Genet. 14, 1065-1073
35. Janmey, P.A. and Lindberg, U. (2004) Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell Biol. 5, 658-666
36. Watt, S.A., Kular, G., Fleming, I.N., Downes, C.P. and Lucocq, J.M. (2002) Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C δ1. Biochem. J. 363, 657-666
37. Golebiewska, U., Nyako, M., Woturski, W., Zaitseva, I. and McLaughlin, S. (2008) Diffusion coefficient of fluorescent phosphatidylinositol 4,5-bisphosphate in the plasma membrane of cells. Mol. Biol. Cell 19, 1663-1669
38. Shamir, A., Sjoholt, G., Ebstein, R.P., Agam, G. and Steen, V.M. (2001) Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases. Gene 271, 285-291
39. Agam, G., Shaltiel, G., Kozlovsky, N., Shimon, H. and Belmaker, R.H. (2003) Lithium inhibitable enzymes in postmortem brain of bipolar patients. J. Psychiatr. Res. 37, 433-442
40. Shaltiel, G., Shamir, A., Nemanov, L., Yaroslavsky, Y., Nemets, B., Ebstein, R.P., Belmaker, R.H. and Agam, G. (2001) Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients. World J. Biol. Psychiatry 2, 95-98
41. Ohnishi, T., Yamada, K., Ohba, H., Iwayama, Y., Toyota, T., Hattori, E., Inada, T., Kunugi, H., Tatsumi, M., Ozaki, N. et al. (2007) A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology 32, 1727-1737
42. Sjoholt, G., Gulbrandsen, A.K., Lovlie, R., Berle, J.O., Molven, A. and Steen, V.M. (2000) A human myo-inositol monophosphatase gene ( IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol. Psychiatry 5, 172-180
43. Sjoholt, G., Ebstein, R.P., Lie, R.T., Berle, J.O., Mallet, J., Deleuze, J.F., Levinson, D.F., Laurent, C., Mujahed, M., Bannoura, I. et al. (2004) Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry 9, 621-629
44. Stopkova, P., Saito, T., Fann, C.S., Papolos, D.F., Vevera, J., Paclt, I., Zukov, I., Stryjer, R., Strous, R.D. and Lachman, H.M. (2003) Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123, 50-58